Drugs / CTP-730
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02404922 | Mar → Jun 2015 | — | Concert Pharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT02239081 | Sep 2014 → Jan 2015 | — | Concert Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTP-730 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02404922 ↗ |
| Route | Oral | “oral suspension, once daily.” NCT02239081 ↗ |